Filing Details
- Accession Number:
- 0001209191-13-036095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-10 16:11:10
- Reporting Period:
- 2013-07-08
- Filing Date:
- 2013-07-10
- Accepted Time:
- 2013-07-10 16:11:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1429894 | Thomas Shea | C/O Nxstage Medical, Inc. 350 Merrimack Street Lawrence MA 01843 | Svp Manufacturing Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-08 | 5,000 | $4.32 | 20,071 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-08 | 7,000 | $14.34 | 13,071 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-08 | 5,000 | $0.00 | 5,000 | $4.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,000 | 2009-03-31 | 2015-03-30 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
- This stock option vests as to 25% of the underlying shares on March 31, 2009 and then in 36 equal monthly installments thereafter.